- Kathleen Sebelius cites pharmacists' importance as Rite Aid CEO introduces Obamacare resource program
- Rite Aid posts $71.5 million profit in third quarter 2014
- New Rite Aid group VP pharmacy initiatives and clinical services to oversee Wellness Ambassador program
- Rite Aid introduces interactive higi health stations across the chain
- Jean Coutu Group profits soar in Q2
NEW YORK — The Jean Coutu Group is selling the last of its shares in Rite Aid Corp., according to a regulatory filing.
In a filing with the Securities and Exchange Commission Wednesday, the Quebec-based pharmacy retailer announced that it would sell 65.4 million shares in Rite Aid at a price of $192.2 million.
Jean Coutu originally acquired 250 million shares of Rite Aid in 2007 as part of Rite Aid's acquisition of the Brooks and Eckerd drug store chains, originally announced in 2006. In June 2013, Jean Coutu announced the sale of 72.5 million shares of Rite Aid, reducing its holdings in the company to 7.2%.
In another SEC filing Wednesday, Rite Aid said its offer for all outstanding 9.5% senior notes had expired, and that most of the $800 million in notes had been put up for sale.
Are you a nurse practitioner or physician's assistant? Join our Facebook group to get all the latest news dedicated to delivering healthcare services to patients in retail pharmacy clinics.